| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
disease | 0.200 | None | 0.938 | 1 | 1 | 1980 | 2019 | |||||||||
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
disease | 0.700 | None | 0.966 | 1 | 1 | 1983 | 2019 | ||||||||
|
lipoprotein(a) | 0.444 | 0.769 | 6.6E-89 |
|
disease | 0.500 | None | 0.968 | 4 | 4 | 1988 | 2019 | ||||||||
|
lipoprotein(a) like 2, pseudogene | 0.626 | 0.731 |
|
disease | 0.160 | None | 1.000 | 1 | 1 | 1991 | 2017 | |||||||||
|
lipoprotein lipase | 0.474 | 0.808 | 1.3E-09 |
|
disease | 0.400 | None | 0.987 | 1 | 1 | 1993 | 2020 | ||||||||
|
phospholipase A2 group VII | 0.537 | 0.769 | 5.3E-22 |
|
disease | 0.500 | None | 0.975 | 1 | 1 | 1997 | 2019 | ||||||||
|
lipase C, hepatic type | 0.585 | 0.654 | 3.3E-07 |
|
disease | 0.200 | None | 0.941 | 1 | 1 | 1997 | 2016 | ||||||||
|
HNF1 homeobox A | 0.478 | 0.846 | 0.96 |
|
disease | 0.470 | None | 1.000 | 1 | 1 | 1998 | 2017 | ||||||||
|
lipase A, lysosomal acid type | 0.564 | 0.654 | 5.5E-07 |
|
disease | 0.160 | None | 1.000 | 2 | 1 | 2003 | 2019 | ||||||||
|
scavenger receptor class B member 1 | 0.559 | 0.731 | 6.6E-02 |
|
disease | 0.180 | None | 1.000 | 1 | 1 | 2003 | 2018 | ||||||||
|
platelet and endothelial cell adhesion molecule 1 | 0.426 | 0.846 |
|
disease | 0.170 | None | 1.000 | 1 | 1 | 2003 | 2017 | |||||||||
|
CDKN2B antisense RNA 1 | 0.491 | 0.769 |
|
disease | 0.200 | None | 1.000 | 12 | 8 | 2007 | 2020 | |||||||||
|
MIA SH3 domain ER export factor 3 | 0.716 | 0.423 | 3.7E-02 |
|
disease | 0.150 | None | 1.000 | 2 | 1 | 2007 | 2017 | ||||||||
|
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1 like | 0.674 | 0.538 | 1.9E-12 |
|
disease | 0.120 | None | 1.000 | 1 | 1 | 2007 | 2012 | ||||||||
|
SMAD family member 3 | 0.415 | 0.923 | 0.80 |
|
disease | 0.140 | None | 1.000 | 1 | 1 | 2007 | 2018 | ||||||||
|
cadherin EGF LAG seven-pass G-type receptor 2 | 0.656 | 0.577 | 1.00 |
|
disease | 0.130 | None | 1.000 | 2 | 4 | 2008 | 2017 | ||||||||
|
transcription factor 7 like 2 | 0.485 | 0.846 | 1.00 |
|
disease | 0.450 | None | 1.000 | 1 | 1 | 2008 | 2019 | ||||||||
|
muscle RAS oncogene homolog | 0.590 | 0.731 | 0.92 |
|
disease | 0.400 | None | 1.000 | 3 | 2 | 2009 | 2017 | ||||||||
|
solute carrier family 22 member 3 | 0.531 | 0.846 | 7.8E-10 |
|
disease | 0.160 | None | 1.000 | 2 | 1 | 2009 | 2017 | ||||||||
|
interleukin 6 receptor | 0.471 | 0.846 | 3.2E-05 |
|
disease | 0.190 | None | 1.000 | 1 | 1 | 2009 | 2020 | ||||||||
|
aldehyde dehydrogenase 1 family member A2 | 0.578 | 0.692 | 0.36 |
|
disease | 0.110 | None | 1.000 | 1 | 1 | 2009 | 2016 | ||||||||
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 | 0.450 | 0.885 | 1.00 |
|
disease | 0.130 | None | 1.000 | 2 | 1 | 2010 | 2017 | ||||||||
|
aldehyde dehydrogenase 2 family member | 0.457 | 0.885 | 3.4E-10 |
|
disease | 0.200 | None | 1.000 | 1 | 1 | 2010 | 2020 | ||||||||
|
fatty acid desaturase 2 | 0.575 | 0.692 | 1.00 |
|
disease | 0.150 | None | 1.000 | 1 | 1 | 2010 | 2019 | ||||||||
|
fatty acid desaturase 1 | 0.582 | 0.769 | 0.37 |
|
disease | 0.160 | None | 1.000 | 1 | 1 | 2010 | 2018 |